KMPH CEO Travis Mickle Discusses ADHD Drug Azstarys Approval

The President and CEO of KemPharm (KMPH), Travis Mickle, weighs in on the ADHD drug Azstarys that has been approved in patients age 6 years and older. The company specializes in pharmaceuticals and is engaged in discovery and development of prodrugs.

The Watch List

25 Mar 2021

ON AIR
7:00 am
Futures

Get Market Minute

Daily insights for every investor

FOLLOW US

KMPH CEO Travis Mickle Discusses ADHD Drug Azstarys Approval

The President and CEO of KemPharm (KMPH), Travis Mickle, weighs in on the ADHD drug Azstarys that has been approved in patients age 6 years and older. The company specializes in pharmaceuticals and is engaged in discovery and development of prodrugs.

The Watch List

25 Mar 2021

ON AIR
7:00 am
Futures

Get Market Minute

Daily insights for every investor

FOLLOW US